Matt Christopher, MD, PhD, from the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, addresses current AML treatments and shares what new treatments are on the horizon.
This program is part of the June 2024 New + Emerging Treatments webinar series, which is hosted by the Leukemia Research Foundation for leukemia patients, caregivers, family members, and healthcare professionals. Each hour-long webinar is dedicated to a specific subtype of leukemia and is followed by a Q+A session.